Swedencare AB (publ) (SECARE) Earnings Call Transcripts

21 earnings calls from February 2022 to July 22, 2026

OM SE Health Care Pharmaceuticals

Swedencare AB (publ)'s Latest Earnings Call - June 17, 2026

In the Q2 update for fiscal year 2026, Swedencare AB highlighted ongoing challenges but also positive developments, particularly in online sales and new market expansions. Revenue growth is expected to remain in double digits, with management maintaining a gross margin target of 58%-59%. The company anticipates improved profitability in Q3, following a challenging first half due to supply chain issues and distributor mergers affecting veterinary sales. Overall, the sentiment is cautiously optimistic as the company navigates these transitions.

Reported metrics

MetricValueContext
Revenue Growth double-digit organic growth (positive) expected growth for Q2
Gross Margin 58%-59% (inline) consistent with previous quarters
EBITDA Margin 19.6% (positive) expected to improve compared to last year
Net Debt to EBITDA 2.8 (inline) expected to remain similar in Q2
Veterinary Sales Exposure $20M-$30M (negative) estimated direct sales to merging distributors
Amazon Sales Normalization early to mid-Q3 (positive) expected timeline for resolution of issues

Guidance from management

Management expects improved profitability in Q3, with no material one-offs anticipated. They maintain a gross margin target of 58%-59% for the quarter.

What management said

Welcome to Swedencare's pre-quarter update, where Jenny and Hakan will provide a short presentation, followed by a Q&A. So please raise your hand if you have any questions. Over to you, Jenny and Hakan.
— Emma Nordgren, June 17, 2026 earnings call
It's difficult to say because we also sell products to -- we manufacture products to brands that sell to them. So it's a very complex lots -- I mean, we have many products ending up in these sales channels. But direct sales for us on a yearly basis, I would say that it's between 20 million to -- I don't have the exact number, so USD 20 million, USD 30 million. That's my best guess, but don't hold me to it.
— Hakan Lagerberg, June 17, 2026 earnings call

What analysts pressed on

Analysts expressed concerns about the impact of the distributor merger on veterinary sales, with questions about how structural changes could affect overall market dynamics. There is uncertainty regarding inventory levels and order changes during this transition.

Main topics on the call

Read the full Swedencare AB (publ) transcript (June 17, 2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

About Swedencare AB (publ)

Swedencare AB (publ) (SECARE) is a publicly listed company in the Pharmaceuticals industry, within the Health Care sector. It trades on OM and is based in SE. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 21 calls on record spanning February 17, 2022 to July 22, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 21 Swedencare AB (publ) earnings call transcripts on record, spanning February 17, 2022 to July 22, 2026. Based on this history, Swedencare AB (publ) reports quarterly. The most recent call on file is dated July 22, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
SECARE
Exchange
OM
Country
SE
Sector
Health Care
Industry
Pharmaceuticals
Calls on record
21
First call
February 17, 2022
Most recent
July 22, 2026
Reporting cadence
quarterly
Quarter Date
Earnings Calls Jul 22, 2026 Read transcript
Shareholder/Analyst Calls Jun 17, 2026 Read transcript
Analyst/Investor Day Jun 2, 2026 Read transcript
Q1 FY2026 Apr 23, 2026 Read transcript
Shareholder/Analyst Calls Mar 20, 2026 Read transcript
Earnings Calls Feb 12, 2026 Read transcript
Q3 FY2025 Oct 22, 2025 Read transcript
Q1 FY2025 Apr 24, 2025 Read transcript
Earnings Calls Feb 13, 2025 Read transcript
Q3 FY2024 Oct 23, 2024 Read transcript
Earnings Calls Jul 25, 2024 Read transcript
Q1 FY2024 Apr 25, 2024 Read transcript
Earnings Calls Feb 15, 2024 Read transcript
Q3 FY2023 Oct 25, 2023 Read transcript
Earnings Calls Jul 27, 2023 Read transcript
Q1 FY2023 Apr 28, 2023 Read transcript
Earnings Calls Feb 16, 2023 Read transcript
Q3 FY2022 Oct 27, 2022 Read transcript
Q2 FY2022 Jul 28, 2022 Read transcript
Q1 FY2022 May 12, 2022 Read transcript
Earnings Calls Feb 17, 2022 Read transcript